Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cannabist Co Holdings (CBSTF) Capital Expenditures (2021 - 2025)

Cannabist Co Holdings' Capital Expenditures history spans 5 years, with the latest figure at $248000.0 for Q3 2025.

  • For Q3 2025, Capital Expenditures fell 83.66% year-over-year to $248000.0; the TTM value through Sep 2025 reached $1.2 million, up 1428.74%, while the annual FY2024 figure was $1.2 million, 70.22% down from the prior year.
  • Capital Expenditures for Q3 2025 was $248000.0 at Cannabist Co Holdings, down from $1.8 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $101.7 million in Q4 2021 and bottomed at -$66.4 million in Q4 2022.
  • The 5-year median for Capital Expenditures is $1.8 million (2025), against an average of $6.8 million.
  • The largest annual shift saw Capital Expenditures plummeted 165.26% in 2022 before it soared 10300.0% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $101.7 million in 2021, then tumbled by 165.26% to -$66.4 million in 2022, then surged by 93.62% to -$4.2 million in 2023, then soared by 30.37% to -$2.9 million in 2024, then soared by 108.41% to $248000.0 in 2025.
  • Per Business Quant, the three most recent readings for CBSTF's Capital Expenditures are $248000.0 (Q3 2025), $1.8 million (Q2 2025), and $2.0 million (Q1 2025).